Location History:
- Jadavpur, IN (2020)
- Kolkata, IN (2021)
Company Filing History:
3 out of 2,096 
1 out of 4 Years Active: 2020-2024
Title: Arindam Talukdar: Innovator in Biomedical Research
Introduction
Arindam Talukdar is a notable inventor based in Kolkata, India, recognized for his significant contributions to biomedical research. With a total of three patents to his name, he has made strides in developing compounds aimed at treating serious diseases.
Latest Patents
Talukdar's recent patents include innovative compounds targeting essential biological processes. One of his latest inventions is a "Bicycle topoisomerase I inhibiting compounds, process for preparation and use thereof." This invention focuses on treating diseases such as breast cancer by inhibiting the topoisomerase I enzyme, facilitating a physiologically beneficial response. The process of preparing these compounds is also detailed within this patent.
Another significant patent is on "Purine-based compounds as toll-like receptor 9 antagonist." This invention introduces novel purine-based compounds that inhibit signaling through Toll-like receptors. These compounds are useful in the treatment of autoimmune diseases and inflammation, specifically targeting situations where aberrant activation of TLR9 occurs.
Career Highlights
Arindam Talukdar has a noteworthy career, having worked with esteemed organizations such as the Council of Scientific & Industrial Research and the Indian Association for the Cultivation of Science. His affiliations with such institutions highlight his commitment to scientific research and innovation.
Collaborations
Throughout his career, Talukdar has collaborated with other talented researchers, including Ayan Mukherjee and Biswajit Kundu. These collaborations have likely enriched his work and contributed to advancing the field of biomedical research.
Conclusion
Arindam Talukdar stands out as a dedicated inventor in the realm of biomedical innovations. His patents not only showcase his inventive spirit but also have the potential to significantly impact the treatment of critical health issues such as cancer and autoimmune diseases. With ongoing contributions to research and development, Talukdar remains a key figure in the scientific community.